Home
>
National Drug Code (NDC)
>
Methylphenidate Hydrochloride
Methylphenidate Hydrochloride - 67767-201-25 - (Methylphenidate Hydrochloride)
Drug Information of Methylphenidate Hydrochloride
| Product NDC: | 67767-201 |
| Proprietary Name: | Methylphenidate Hydrochloride |
| Non Proprietary Name: | Methylphenidate Hydrochloride |
| Active Ingredient(s): | 30 mg/1 & nbsp; Methylphenidate Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Methylphenidate Hydrochloride
| Product NDC: | 67767-201 |
| Labeler Name: | Actavis South Atlantic LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078458 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120103 |
Package Information of Methylphenidate Hydrochloride
| Package NDC: | 67767-201-25 |
| Package Description: | 250 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (67767-201-25) |
NDC Information of Methylphenidate Hydrochloride
| NDC Code | 67767-201-25 |
| Proprietary Name | Methylphenidate Hydrochloride |
| Package Description | 250 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (67767-201-25) |
| Product NDC | 67767-201 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Methylphenidate Hydrochloride |
| Dosage Form Name | CAPSULE, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20120103 |
| Marketing Category Name | ANDA |
| Labeler Name | Actavis South Atlantic LLC |
| Substance Name | METHYLPHENIDATE HYDROCHLORIDE |
| Strength Number | 30 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] |
